Navigation Links
NW Bio to Present at the Cancer Immunotherapy Summit
Date:2/29/2012

;

The Company has a broad platform technology for dendritic cell-based vaccines.  The Company's lead clinical trial is a 240-patient Phase II trial in newly diagnosed Glioblastoma multiforme ("GBM"), the most aggressive and lethal brain cancer. In the earlier Phase I/II clinical trials for GBM brain cancer, patients who received DCVax® showed a median survival of 3 years compared with median survival of 14.6 months for patients who received standard of care (surgery, radiation and chemotherapy).  Patients who received DCVax® also experienced a substantially longer time to tumor recurrence: a median of 2 years, compared with 6.9 months in patients who received standard of care.  DCVax® was well-tolerated, with no toxic side effects.

The Company also previously received clearance from the FDA for a 612-patient Phase III trial in prostate cancer, and clearance from the FDA for Phase I trials in multiple other cancers.  The Company has also conducted a Phase I/II trial with DCVax® for recurrent metastatic ovarian cancer.  For further information about clinical sites and about the Company, please visit the Company's web site at www.nwbio.com.

Disclaimer

Statements made in this news release that are not historical facts, including statements concerning future treatment of patients with GBM using DCVax® and future clinical trials, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Words such as "expects," "believes," "intends," and similar expressions are intended to identify forward-looking statements.  Actual results may differ materially from those projected in any forward-looking statement.  Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated, such as the Company's ability to raise additional capita
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference
2. Perrigo Company to Present at the RBC Capital Markets Healthcare Conference
3. Isis Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
4. Frost & Sullivan New Product Innovation Award Presented to Brainsway for Its Deep Transcranial Magnetic Stimulation (dTMS) Device
5. Generex Subsidiary Antigen Express to Present at Prestigious Cancer Immunotherapy Summit
6. Masimo to Present at 24th Annual ROTH Conference
7. GP Strategies Corporation to Present at Baird Business Solutions Conference
8. Unigene to Present at IBCs 4th Annual AsiaTIDES Oligonucleotide and Peptide® Conference
9. Nektar Presents Positive Proof-of-Concept Clinical Data for Its New Opioid Molecule, NKTR-181, at American Academy of Pain Medicines 28th Annual Meeting
10. Optimer Pharmaceuticals to Present at the 32nd Annual Cowen Health Care Conference
11. Auxilium Pharmaceuticals to Present at the 2012 Cowen Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Sept. 1, 2015  AccuTec Blades, Inc. today announced ... Blades division.  EPC announced in May 2015 its intent ... Verona, Virginia and Obregon, Mexico ... sale process. Rick Gagliano , ... Blades said, "Our new name, AccuTec Blades, reflects the ...
(Date:9/1/2015)... , Sept. 1, 2015 Ardelyx, ... company focused on gastrointestinal and cardio-renal diseases, today ... of the option and license agreement for Ardelyx,s ... There was no payment associated with termination and ... 2014, Ardelyx and Sanofi entered into an option ...
(Date:9/1/2015)... 1, 2015  Dynatronics Corporation (NASDAQ: DYNT ... the First Annual Ladenburg Thalmann Healthcare Conference at ... Kelvyn H. Cullimore, Jr. , Chairman and President, ... representatives on Tuesday, September 29 at 10:30 a.m. ... will showcase leading-edge companies in the healthcare arena. ...
Breaking Medicine Technology:AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3
(Date:9/2/2015)... ... 2015 , ... On September 9, 2015, over 27,000 people from all over ... convention to date for the state of Utah. , “We are thrilled with the ... David Stirling, doTERRA CEO. “One of the most exciting elements of our convention is ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... Brain Aneurysm Awareness Month , which was established by the Foundation in ... awareness and education, and helping fund more research remains our top priority,” commented ...
(Date:9/2/2015)... ... ... Mobile working is increasingly more important, as business professionals are looking to ... are being launched, and mobile device usage as a whole is something people around ... personal lives. What's more people are expecting mobile versions of their favorite software. , ...
(Date:9/1/2015)... ... 2015 , ... September is National Prostate Cancer Awareness Month and Florida Hospital ... each year in the United States. , Prostate cancer is to men what breast ... 1 in 7 men. One new case occurs every 2.3 minutes and a man ...
(Date:9/1/2015)... ... 2015 , ... According to a study published August 25th in ... in a three year study about weight loss and diabetes were far more likely ... loss surgery at the onset of the trial. In fact, the participants in the ...
Breaking Medicine News(10 mins):Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:New Mobility Experience From Winscribe 2Health News:New Mobility Experience From Winscribe 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2
... Veteran,s charity supports Obama administration,s announcement of plan ... system available to wounded veterans , OSSINING, N.Y., ... Salute America,s Heroes , a leading non-partisan, ... veterans returning from Iraq and Afghanistan and their ...
... FRANCISCO, April 9 Burrill & Company, a San ... principal activities in Venture Capital, Private Equity, Merchant Banking ... promotions: , Tiba Aynechi to Director, Merchant Banking ... Patel to Senior Associate, Merchant Banking Tiba Aynechi ...
... previous obesity , , THURSDAY, April 9 (HealthDay News) -- ... at increased risk for physical disabilities, even if they,ve shed ... a new U.S. study. , "In both men and women, ... developing mobility limitations in old age, and the longer they ...
... Legacy Foundation(R) and ASPCA(R) Urge Pet Owners to Safeguard Their ... April 9 The American Legacy Foundation(R) is challenging pet ... of April, which kicks off Prevention of Cruelty to Animals ... safe levels of exposure to secondhand smoke -- for humans ...
... Largest Breast Cancer Organization Investing $60 Million to Research Despite ... Testing whether a powerful ingredient in marijuana can help slow ... of six Bay Area breast cancer studies being funded this ... leader in the breast cancer movement announced today. The projects ...
... touts five of the first 23 recognized facilities.MILWAUKEE, April 9 ... is home to five breast centers out of ... Program for Breast Centers ( NAPBC ), a ... http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b )The first facility named in Wisconsin, was ...
Cached Medicine News:Health News:Coalition to Salute America's Heroes(TM) Applauds President's Announcement to Create Joint Virtual Lifetime Records 2Health News:Burrill & Company Announces Promotions 2Health News:Extra Pounds in Mid-Life Affect Later Mobility 2Health News:Tobacco is Toxic for Toto Too 2Health News:Tobacco is Toxic for Toto Too 3Health News:N. California Researchers Testing Whether Marijuana Chemical Can Slow Cancer Growth, With Funding by Susan G. Komen for the Cure(R) 2Health News:N. California Researchers Testing Whether Marijuana Chemical Can Slow Cancer Growth, With Funding by Susan G. Komen for the Cure(R) 3Health News:Aurora Health Care Breast Centers Receive National Recognition 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: